FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the area of chemical and pharmaceutical industry, namely to a method for production of a preparation of a sodium salt of deoxyribonucleic acid in form of a sterile water solution, characterized by a solution of an auxiliary substance constituting sodium chloride or sodium citrate at a concentration of up to 0.01 to 0.1 g/l being preliminarily prepared, then a weighed amount of the sodium salt of deoxyribonucleic acid being dissolved in the resulting solution to obtain a concentration of 0.1 to 25.0 g/l, sodium chloride being added up to the concentration of auxiliary substances of 5.0 to 12.0 g/l, the resulting solution being heated to a temperature of 30 to 35°С followed by sterilising filtration and packaging.
EFFECT: invention allows producing a medicinal form that is sterile and apyretic and retains the nativeness of the active substance.
2 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING ANTIVIRAL DRUG | 2020 |
|
RU2739186C1 |
| METHOD FOR PRODUCTION OF APYROGENIC IMMUNOMODULATING AGENT | 2006 |
|
RU2309759C1 |
| METHOD FOR PRODUCING IMMUNOTROPIC STERILE APYROGENIC TOLERANT PREPARATION BASED ON LOW-MOLECULAR NATIVE DEOXYRIBONUCLEIC ACID SODIUM SALT | 2003 |
|
RU2236853C1 |
| DERINAT SUPPOSITORIES TO BE USED IN MEDICAL PRACTICE | 2009 |
|
RU2429854C2 |
| PROCESS OF PRODUCTION OF SODIUM DNA SALT FROM ANIMAL RAW MATERIAL AND BIOREACTOR FOR ITS REALIZATION | 1993 |
|
RU2005724C1 |
| METHOD OF PREPARING IMMUNOTROPIC ANTIVARAL DRUG | 2000 |
|
RU2172632C1 |
| SODIUM DEOXYRIBONUCLEATE, SUBLINGUAL ORODISPERSIBLE TABLETS AND METHOD OF THEIR OBTAINING | 2016 |
|
RU2651043C1 |
| PROCESS FOR PREPARING MEDICINAL FORMS OF DNA SODIUM SALT | 1993 |
|
RU2007165C1 |
| ANTIVIRAL IMMUNOTROPIC AGENT | 1999 |
|
RU2158592C1 |
| METHOD OF MANUFACTURE OF STERILE PHARMACEUTICAL SUBSTANCE | 2018 |
|
RU2673802C1 |
